Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1933 Nov 30;58(6):731–755. doi: 10.1084/jem.58.6.731

CHEMOIMMUNOLOGICAL STUDIES ON THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS

I. THE ISOLATION AND PROPERTIES OF THE ACETYL POLYSACCHARIDE OF PNEUMOCOCCUS TYPE I

Oswald T Avery 1, Walther F Goebel 1
PMCID: PMC2132296  PMID: 19870226

Abstract

The soluble specific substance of Pneumococcus Type I has been chemically isolated from the bacterial cells and from autolyzed cultures as an acetyl polysaccharide. So far as could be determined by the methods employed, the acetyl polysaccharide in highly purified form absorbs from Type I antipneumococcus serum all demonstrable type-specific precipitins, agglutinins and protective antibodies. Mice injected intraperitoneally with minute quantities of the acetyl polysaccharide develop active immunity to subsequent infection with Pneumococcus Type I. The immunity thus induced is type-specific. In several instances purpura has been observed in mice following the injection of larger amounts of the acetyl polysaccharide. Under the experimental conditions of this study, no type-specific precipitins, agglutinins or protective antibodies were demonstrable in the serum of rabbits following repeated intravenous injections of the Type I acetyl polysaccharide. The treated rabbits were not immune to subsequent infection with Pnemnococcus Type I. The acetyl polysaccharide is readily converted into its deacetylated derivative by treatment with dilute alkali. The chemical and immunological properties of the deacetylated polysaccharide are identical with those of the soluble specific substance in the chemical form in which it was originally isolated; the deacetylated form of the specific carbohydrate is non-antigenic, does not produce purpura in mice, and only incompletely absorbs the type-specific antibodies from Type I antipneumococcus serum. The immunological significance of the acetyl polysaccharide and its possible relationship to the specific substances isolated from Pneumococcus Type I by other workers are discussed.

Full Text

The Full Text of this article is available as a PDF (1.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dale H. H. ACADEMIC AND INDUSTRIAL RESEARCH IN THE FIELD OF THERAPEUTICS. Science. 1933 Jun 2;77(2005):521–527. doi: 10.1126/science.77.2005.521. [DOI] [PubMed] [Google Scholar]
  2. Enders J. F. A NOTE ON THE SPECIFIC AGGLUTINATION OF PNEUMOCOCCUS TYPES I, II AND III. J Exp Med. 1932 Jan 31;55(2):191–202. doi: 10.1084/jem.55.2.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Enders J. F. A TYPE SPECIFIC SUBSTANCE DISTINCT FROM THE SPECIFIC CARBOHYDRATE IN PNEUMOCOCCUS TYPE I. J Exp Med. 1930 Jul 31;52(2):235–252. doi: 10.1084/jem.52.2.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Goodner K. EXPERIMENTAL INTRADERMAL PNEUMOCOCCUS INFECTION IN RABBITS. J Exp Med. 1928 Jun 30;48(1):1–20. doi: 10.1084/jem.48.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Heidelberger M., Avery O. T. THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : SECOND PAPER. J Exp Med. 1924 Aug 31;40(3):301–317. doi: 10.1084/jem.40.3.301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Heidelberger M., Avery O. T. THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS. J Exp Med. 1923 Jun 30;38(1):73–79. doi: 10.1084/jem.38.1.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Heidelberger M., Goebel W. F., Avery O. T. THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : THIRD PAPER. J Exp Med. 1925 Oct 31;42(5):727–745. doi: 10.1084/jem.42.5.727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Perlzweig W. A., Keefer C. S. THE IMMUNIZING ANTIGEN OF THE PNEUMOCOCCUS : III. THE PURIFICATION OF THE WATER-SOLUBLE ANTIGEN. J Exp Med. 1925 Nov 30;42(6):747–752. doi: 10.1084/jem.42.6.747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Perlzweig W. A., Steffen G. I. STUDIES ON PNEUMOCOCCUS IMMUNITY : III. THE NATURE OF PNEUMOCOCCUS ANTIGEN. J Exp Med. 1923 Jul 31;38(2):163–182. doi: 10.1084/jem.38.2.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Sabin A. B. ON THE PRESENCE IN ANTIPNEUMOCOCCUS SERUM OF TYPE-SPECIFIC PROTECTIVE ANTIBODY NOT NEUTRALIZED BY HOMOLOGOUS SPECIFIC SOLUBLE SUBSTANCE. J Exp Med. 1931 Jan 1;53(1):93–107. doi: 10.1084/jem.53.1.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ward H. K. AN EXAMINATION OF THE MECHANISM OF PNEUMOCOCCUS IMMUNITY BY MEANS OF BACTERICIDAL MEASUREMENTS : II. THE REACTION BETWEEN THE ANTICARBOHYDRATE ANTIBODY AND TYPE-SPECIFIC PRODUCTS OF THE ORGANISM. J Exp Med. 1932 Mar 31;55(4):519–530. doi: 10.1084/jem.55.4.519. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES